PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medshine Discovery Inc.

USPTO PatentsView assignee record - 64 granted patents across 10 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medshine ranks #5,380 of 49,997 tracked US assignees by granted-patent volume, with 64 patents across 10 technology areas.

#5,380
of 49,997 US assignees by volume
Top 22%
by Innovation Score (45.9/100)
18.3
avg claims per patent
+390%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5380 · Foreign Corporation #5,380 · 64 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 64 grants
  • UPPER-Q #5,380/49,997
  • PHOTO-FINISH Mc10
  • CPC-FOCUS C07D · 10 areas
  • INNOV-PAR 45.9/100
  • CLAIMS-RICH 18.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +390% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mc10, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medshine’s 45.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Medshine

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Medshine's Innovation Score is 45.9/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Medshine?

Each dot is one of Medshine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medshine’s own 18.3 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medshine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 63.964.064.06464.064.064.1 010203040 Granted patents (volume) Avg claims / patent Mc10, Inc. - 64, 28.3Mc10Mechoshade Systems, LLC - 64, 17.88Mechoshade SystemsMedtronic Vascular Galway Unlimited Company - 64, 16.64Medtronic Vascula…Mitek Systems, Inc. - 64, 18.89Mitek SystemsMeritor Heavy Vehicle Braking Systems (UK) Limited - 64, 16.48Meritor Heavy Veh…Mid-West Metal Products Company, Inc. - 64, 9.42Mid-west Metal Pr…Nisshinbo Holdings Inc. - 64, 10.5Nisshinbo HoldingsNarrative Science LLC - 64, 37.22Narrative ScienceMedshine Discovery Inc. - 64, 18.31Medshine Discovery
Medshine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medshine's grants concentrate

Medshine Discovery Inc. is a focused PatentsView assignee: 10 CPC subclasses with 96.9% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2022 (17 grants) versus a trough of 1 in 2017. By volume, Medshine sits between Mc10, Inc. and Narrative Science LLC.

Medshine's three-year grant acceleration

From 2019–2021 to 2022–2024, Medshine Discovery Inc. moved from 23 to 32 grants (1.39x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Medshine's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medshine holds 64 patents at rank #5,381, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medshine

By rank, the assignees closest to #5,381 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Medshine's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medshine, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Medshine ranks #122 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Yahoo Japan Corporation 46 Lupin Limited 46 Prospira Corporation 46 Unity IPR ApS 46

Similar claim depth

Nearest assignees by average claims per patent (18.3 here).

Shanghai Kohler Electronics, Ltd. 18.3 avg Neustar, Inc. 18.3 avg Twelve, Inc. 18.3 avg Dura Operating, LLC 18.3 avg

Medshine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Medshine Discovery Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 1.6%
2018 3 4.7%
2019 6 9.4%
2020 7 10.9%
2021 10 15.6%
2022 17 26.6%
2023 13 20.3%
2024 2 3.1%
2025partial year 5 7.8%

Which technologies does Medshine Discovery Inc. patent most?

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medshine Discovery Inc.'s patent record in context - here's where to go next.

  • Medshine Discovery Inc.'s lead technology class is C07D (Heterocyclic Compounds), 96.9% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #5,380 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Medshine Discovery Inc. against Mc10, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.